Free Trial

Alpha Tau Medical (DRTS) Earnings Date, Estimates & Call Transcripts

Alpha Tau Medical logo
$7.32 -0.22 (-2.86%)
As of 02:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Alpha Tau Medical Earnings Summary

Alpha Tau Medical posted Q4 2025 earnings on March 9, 2026, reporting an EPS of -$0.14, which missed the consensus estimate of -$0.13 by $0.01. With a trailing EPS of -$0.53, Alpha Tau Medical's earnings are expected to grow next year, from ($0.50) to ($0.41) per share.

Upcoming
Earnings Date
May. 18Before Market OpensEstimated
Consensus EPS
(Mar. 9)
-$0.13
Actual EPS
(Mar. 9)
-$0.14 Missed By -$0.01

Q4 2025 Earnings Resources

DRTS Upcoming Earnings

Alpha Tau Medical's Q1 2026 earnings is estimated for Monday, May 18, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, May 19, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Alpha Tau Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Tau Medical and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

DRTS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Alpha Tau Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.13-$0.13-$0.13
Q2 20261-$0.13-$0.13-$0.13
Q3 20261-$0.13-$0.13-$0.13
Q4 20261-$0.13-$0.13-$0.13

Alpha Tau Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/18/2026
(Estimated)
--------
3/9/2026Q4 2025-$0.13-$0.14 -$0.01-$0.14$0.06M-
11/20/2025Q3 2025-$0.12-$0.14 -$0.02-$0.14--
8/11/2025Q2 2025-$0.12-$0.13 -$0.01-$0.13--
5/19/2025Q1 2025-$0.14-$0.12+$0.02-$0.12$0.03M-
3/12/2025Q4 2024-$0.13-$0.13--$0.13--
8/14/2024Q2 2024-$0.13-$0.11+$0.02-$0.11--
5/20/2024Q1 2024-$0.13-$0.11+$0.02-$0.11--

Data powered by Fiscal.ai.

Alpha Tau Medical Earnings - Frequently Asked Questions

Alpha Tau Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 18th, 2026 based off last year's report dates. Learn more on DRTS's earnings history.

In the previous quarter, Alpha Tau Medical (NASDAQ:DRTS) missed the analysts' consensus estimate of ($0.13) by $0.01 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. DRTS's actual earnings.

Alpha Tau Medical (NASDAQ:DRTS) has a recorded net income of -$42.63 million. DRTS has generated -$0.53 earnings per share over the last four quarters.

Alpha Tau Medical's earnings are expected to grow from ($0.50) per share to ($0.41) per share in the next year.


This page (NASDAQ:DRTS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners